德泽佩卢马布可以改善严重的失控喘和鼻炎:病例系列
Shigesato Inoue1,2, Hiroaki Ogata1,3, Yoichi Dotake4
1Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
The journal of allergy and clinical immunology. Global
|April 14, 2025
概括
一种针对胸膜 stromal lymphopoietin (TSLP) 的单克隆抗体Tezepelumab在四名患者中改善了严重的喘和具有鼻息肉的慢性鼻炎. 这表明TSLP抑制可能有利于患有并发性喘和鼻的患者.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
背景情况:
- 严重的喘是一种复杂的疾病,通常与上呼吸道疾病同时发生.
- 胸膜 stromal lymphopoietin (TSLP) 是一种关键的细胞因子,与过敏性炎症有关.
- 佩鲁马布是一种单克隆抗体,旨在阻止TSLP信号传输.
研究的目的:
- 报告四例患有严重喘和带鼻息肉的慢性鼻炎 (CRSwNP) 的患者.
- 评估这些患者tezepelumab治疗的临床结果.
- 探索TSLP抑制对并发性喘和CRSwNP的潜在影响.
主要方法:
- 四名患有严重喘和CRSwNP的患者的病例系列介绍.
- 患者接受了针对TSLP的tzepelumab治疗.
- 进行了对喘控制和鼻症状的临床评估.
主要成果:
- 这四名患者在严重喘恶化和鼻症状方面均有所改善.
- 在这个队列中,tzepelumab治疗与积极的临床结果有关.
- 没有特别强调任何不良事件,这意味着耐受性.
结论:
- 佩鲁马布可能为同时存在严重喘和CRSwNP的患者提供治疗益处.
- 抑制TSLP可能是管理上下呼吸道炎症的潜在治疗策略.
- 需要进一步的研究,包括更大的受控试验,以证实这些发现.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
174
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
174
Drugs Used in Lower Respiratory Disorders: Overview
260
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
260
Asthma-III: Symptoms and Complications
2.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.4K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
147
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
147
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K


